MedPath

The role of naltrexone in opioid toxicity

Not Applicable
Completed
Conditions
Mental and behavioural disorders due to use of opioids
Acute Opioids Toxicity.
Registration Number
IRCT2012062910133N1
Lead Sponsor
oghman-Hakim Toxicological Reserch Center dependent to Shahid-Beheshti University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

The acutely methadone-poisoned patients ;opioid non-dependent patients;

Exclusion criteria:
The addicted patients (Opioid-dependent patients); Active liver disease; Acute methadone poisoning with development of complications (aspiration pneumonia, brain trauma, and cardiogenic or non-cardiogenic pulmonary edema); History of acute coronory syndrome in last 3 weeks

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oxygenation (Arterial Blood Oxygen Saturation in Percent). Timepoint: Continuously up to 48 hours. Method of measurement: Pulseoxymetery.;Ventilation status. Timepoint: every 6 hours up to 48 hours. Method of measurement: Arterial or venous blood gas.;Hospital Stay. Timepoint: Hours. Method of measurement: Based on registration of time and date on medical file.;Acute Complications. Timepoint: Up to 48 hours. Method of measurement: Physical Examination, inspection and paraclinic data.;Respiratory rate per minute. Timepoint: hour to hour up to 48 hours. Method of measurement: physical examination and inspection.
Secondary Outcome Measures
NameTimeMethod
evel of Consciousness. Timepoint: hour to hour Up to 48 hours. Method of measurement: Physical Examination and assessment of neurologic system.;Need to naloxone. Timepoint: During 48 hrs admission. Method of measurement: Dose of Naloxone Received (mg).
© Copyright 2025. All Rights Reserved by MedPath